Alterity Therapeutics Stock Forecast 2022, 2023, 2024, 2025
[Average Rating: 5]
The stock of Alterity Therapeutics has increased 20% in the past month. Alterity Therapeutics stock forecasts for 2022, 2023, 2024, and 2025 should therefore be examined. Alterity Therapeutics Stock Price Target in the future is discussed in the following article.
Before looking at Alterity Therapeutics stock forecast, we must first examine the company’s stock price history & market capitalization.
Page Contents
About Alterity Therapeutics Stock
In Australia, Alterity Therapeutics Limited conducts research and development on therapeutic drugs to treat conditions such as Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders.
ATH434 has completed a Phase I clinical trial for Parkinson’s disease. It is the company’s lead drug candidate.
Market Cap | 48.043M |
Beta (5Y Monthly) | 1.02 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3600 |
Earnings Date | N/A |
Alterity Therapeutics Forecast 2022
Date | Stock Price |
|---|---|
February 2022 | 0.0668 |
Alterity Therapeutics Forecast 2023
Date | Stock Price |
|---|---|
January 2023 | 0.0362 |
February 2023 | 0.0581 |
Alterity Therapeutics Forecast 2024
Date | Stock Price |
|---|---|
January 2024 | 0.0256 |
February 2024 | 0.0488 |
Alterity Therapeutics Forecast 2025
Date | Stock Price |
|---|---|
January 2025 | 0.0218 |
